@article{3112932,
    title = "Androgen insensitivity syndrome: Clinical features and molecular defects",
    author = "Galani, A. and Kitsiou-Tzeli, S. and Sofokleous, C. and Kanavakis, E. and Kalpini-Mavrou, A.",
    journal = "Vitamins and Hormones",
    year = "2008",
    volume = "7",
    number = "3",
    pages = "217-229",
    publisher = "Hellenic Endocrine Society",
    doi = "10.14310/horm.2002.1201",
    keywords = "androgen receptor;  androgen receptor;  AR protein, human;  hormone, androgen insensitivity syndrome;  gene mutation;  genetic counseling;  genotype;  male infertility;  phenotype;  review;  X chromosome linkage;  androgen insensitivity syndrome;  blood;  female;  genetic screening;  genetics;  hospitalization;  human;  male;  metabolism;  mutation, Androgen-Insensitivity Syndrome;  Female;  Genetic Counseling;  Genetic Screening;  Genotype;  Hormones;  Humans;  Male;  Mutation;  Phenotype;  Receptors, Androgen;  Severity of Illness Index",
    abstract = "The end-organ resistance to androgens has been designated as Androgen Insensitivity Syndrome (AIS), an X-linked disorder caused by mutations in the Androgen Receptor (AR) gene. It is generally accepted that defects in the AR gene prevent the normal development of both internal and external genital structures in 46,XY individuals, causing a variety of phenotypes ranging from male infertility to completely normal female external genitalia. Precise diagnosis requires clinical, hormonal and molecular investigation and is of great importance for appropriate gender assignment and management in general. The complexity of phenotypic presentation of AIS with genotype-phenotype variability of identical mutations complicates both the diagnostic procedure and genetic counseling of the affected families. More than 400 different AR gene mutations have thus far been reported but the receptor structure-function relationship and its phenotypic outcome is not yet fully understood. This review focuses on the clinical features and molecular pathophysiology of AIS and explores the relationship of the molecular defects in the AR gene to their clinical expression."
}